Zurich Cantonal Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Zurich Cantonal Bank’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,055	Closed	-$39.9K	–	2803
2023 Q2	$39.9K	Hold	2,055	–	–	﹤0.01%	2657
2023 Q1	$58.3K	Sell	2,055 -469	-19%	-$13.9K	﹤0.01%	2545
2022 Q4	$73.8K	Sell	2,524 -99	-4%	-$3.15K	﹤0.01%	2451
2022 Q3	$69K	Hold	2,623	–	–	﹤0.01%	2459
2022 Q2	$117K	Sell	2,623 -42	-2%	-$1.93K	﹤0.01%	2137
2022 Q1	$132K	Buy	2,665 +610	+30%	+$29.3K	﹤0.01%	2147
2021 Q4	$105K	Hold	2,055	–	–	﹤0.01%	2493
2021 Q3	$115K	Hold	2,055	–	–	﹤0.01%	2264
2021 Q2	$88K	Hold	2,055	–	–	﹤0.01%	2274
2021 Q1	$86K	Hold	2,055	–	–	﹤0.01%	2214
2020 Q4	$96K	Hold	2,055	–	–	﹤0.01%	2228
2020 Q3	$87K	Hold	2,055	–	–	﹤0.01%	2049
2020 Q2	$99K	Buy	2,055 +1,095	+114%	+$54.6K	﹤0.01%	1944
2020 Q1	$44K	Hold	960	–	–	﹤0.01%	2001
2019 Q4	$58K	Hold	960	–	–	﹤0.01%	2065
2019 Q3	$54K	Hold	960	–	–	﹤0.01%	1988
2019 Q2	$53K	Hold	960	–	–	﹤0.01%	2030
2019 Q1	$48K	Hold	960	–	–	﹤0.01%	2038
2018 Q4	$39K	Hold	960	–	–	﹤0.01%	2176
2018 Q3	$67K	Hold	960	–	–	﹤0.01%	1971
2018 Q2	$73K	Buy	960 +509	+113%	+$32K	﹤0.01%	1869
2018 Q1	$24K	Hold	451	–	–	﹤0.01%	2366
2017 Q4	$24K	Hold	451	–	–	﹤0.01%	2356
2017 Q3	$27K	Hold	451	–	–	﹤0.01%	2148
2017 Q2	$36K	Hold	451	–	–	﹤0.01%	1960
2017 Q1	$37K	Hold	451	–	–	﹤0.01%	1971
2016 Q4	$36K	Buy	451 +65	+17%	+$4.72K	﹤0.01%	1923
2016 Q3	$27K	Hold	386	–	–	﹤0.01%	2106
2016 Q2	$15K	Hold	386	–	–	﹤0.01%	2238
2016 Q1	$16K	Hold	386	–	–	﹤0.01%	2191
2015 Q4	$34K	Buy	386 +293	+315%	+$23.1K	﹤0.01%	1676
2015 Q3	$7K	Buy	+93	New	+$7.74K	﹤0.01%	2308

Other funds holding EGRX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Zurich Cantonal Bank's EGRX Position: Q3 2023 in Review

Zurich Cantonal Bank sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2023, closing a stake of 2,055 shares — an estimated $39.9K sold.

Zurich Cantonal Bank first reported a position in EGRX in Q3 2015 and held it in 32 quarters. The position peaked at $132K in Q1 2022. 107 funds tracked by Wall St. Rank hold EGRX as of Q3 2023.

Zurich Cantonal Bank reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Zurich Cantonal Bank sold 2,055 Eagle Pharmaceuticals, Inc. shares in Q3 2023, an estimated $39.9K.
Zurich Cantonal Bank first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2015 and held it in 32 quarters.
Zurich Cantonal Bank's Eagle Pharmaceuticals, Inc. position peaked at $132K in Q1 2022.
107 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2023.

Based on Zurich Cantonal Bank's 13F filing for Q3 2023, filed 25 Oct 2023.